Primary Malignant Melanoma of Female Urethra: A Case Report and Review of Literature
DOI:
https://doi.org/10.30564/jor.v1i3.1975Abstract
We report a very rare case report of female diagnosed with primary malignant melanoma. A 65 years old diabetic elderly postmenopausal femalepresented with a history of intermittent blood spots on undergarments forfew days. Genital examination revealed a single, tan colored, soft chestnut size and polypoidal non ulcerated mass lesion protruding through theurethral meatus. Mass biopsy revealed poorly differentiated epithelial malignancy and immuno-histological analysis revealed positive with HMB45 and protein S-100 suggestive of melanoma. Metastatic work up for themalignancy was negative. Complete urethrectomy with Mitrofanoff procedure with inguinal lymph node dissection was performed. Histopathological examination was suggestive of malignant melanoma of urethra.Here we discuss the clinicopathological features and management optionpossible in this scenario.Keywords:
Female; urethra; melanomaReferences
[1] Stein BS, Kendall R. Malignant melanoma of the genitourinary tract. J Urol., 1984, 132: 859-68.
[2] Akbas A, Akman T, Erdem MR, Antar B, Kilicarslan I, Onol SY. Female urethral malignant melanoma with vesical invasion: a case report. Kaohsiung J Med Sci., 2010, 26: 96-8.
[3] Iversen K, Robins RE. Mucosal malignant melanomas. Am J Surg., 1980, 139: 660-4.
[4] Oliva E, Quinn TR, Amin MB, Eble JN, Epstein JI, Srigley JR, Young RH. Primary malignant melanoma of the urethra: a clinicopathologic analysis of 15 cases. Am J Surg Pathol., 2000, 24: 785-96.
[5] DiMarco DS, DiMarco CS, Zincke H, Webb MJ, Keeney GL, Bass S, Lightner DJ. Outcome of surgical treatment for primary malignant melanoma of the female urethra. J Urol., 2004, 171: 765-7.
[6] Kim CJ, Pak K, Hamaguchi A, Ishida A, Arai Y, Konishi T, et al. Primary malignant melanoma of the female urethra. Cancer, 1993, 71: 448-51.
[7] Reed CA. Melanosarcoma of the female urethra: Urethrectomy recovery. Am J Obstet Gynecol., 1896, 34: 864-72.
[8] Seetharamu N, Ott PA, Pavlick AC. Mucosal melanomas: a casebased review of the literature. Oncologist., 2010, 15: 772-81.
[9] Oliva E, Quinn TR, Amin MB, Eble JN, Epstein JI, Srigley JR, et al. Primary malignant melanoma of the urethra: A clinicopathologic analysis of 15 cases. Am J Surg Pathol., 2000, 24: 785-96.
[10] Papeš D, Altarac S. Melanoma of the female urethra. Medical Oncology. 2013, 30(1): 329.
[11] Filipkowski LA, Barker MA, Karram MM. Primary genitourinary melanoma presenting as voiding dysfunction. Int Urogynecol J Pelvic Floor Dysfunct., 2009, 20: 1141-3.
[12] Alvarez Kindelan J, Merchan Garcia JA, Olmo Cerezo I, Moreno Rodriguez MM, Gonzalez Arlanzon MM. Primary malignant melanoma of the female urethra. Report of a case. Actas Urol Esp., 2000, 24: 488-90.
[13] L.J. Markovi Pua, A. Relji, B. Kru lin, Primarni maligni melanom enske uretre, Lije Vjesn, 1999, 121: 98-99.
[14] Sugiyama VE, Chan JK, Kapp DS. Management of melanomas of the female genital tract. Curr Opin Oncol., 2008, 20: 565-9.
[15] Kim CJ, Pak K, Hamaguchi A, Ishida A, Arai Y, Konishi T, et al. Primary malignant melanoma of the female urethra. Cancer, 1993, 71: 448-51.
[16] Rikaniadis N, Konstadoulakis MM, Kymionis GD, Tsibloulis B, Peveretos P, Karakousis CP. Long-term survival of a female patient with primary malignant melanoma of the urethra. Eur J Surg Oncol., 1998, 24(6): 607-8.
[17] Katz JI, Grabstald H. Primary malignant melanoma of the female urethra. J Urol., 1976, 116: 454-7.
[18] Dasgupta T, Grabstald H. Melanoma of the genitourinary tract. J Urol., 1965, 93: 607-14.
[19] Mayer R, Fowler JE Jr, Clayton M. Localized urethral cancer in women. Cancer, 1987, 60: 1548-51.
[20] Sheffield MV, Yee H, Dorvault CC, Weilbaecher KN, Eltoum IA, Siegal GP, et al. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol., 2002, 118: 930-6.
[21] Kelley MC, Ollila DW, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma. Semin Surg Oncol., 1998, 14: 283-90.
Downloads
How to Cite
Issue
Article Type
License
Copyright and Licensing
The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.
Journal of Oncology Research publishes accepted manuscripts under Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Authors who submit their papers for publication by Journal of Oncology Research agree to have the CC BY-NC 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for non-commercial use. As long as you follow the license terms and original source is properly cited, anyone may copy, redistribute the material in any medium or format, remix, transform, and build upon the material.
License Policy for Reuse of Third-Party Materials
If a manuscript submitted to the journal contains the materials which are held in copyright by a third-party, authors are responsible for obtaining permissions from the copyright holder to reuse or republish any previously published figures, illustrations, charts, tables, photographs, and text excerpts, etc. When submitting a manuscript, official written proof of permission must be provided and clearly stated in the cover letter.
The editorial office of the journal has the right to reject/retract articles that reuse third-party materials without permission.
Journal Policies on Data Sharing
We encourage authors to share articles published in our journal to other data platforms, but only if it is noted that it has been published in this journal.